Indonesia's exports of basic pharmaceutical products and pharmaceutical preparations to China have experienced an overall declining trend since 2013. The export value stood at $7.4348 million in 2023. Year-on-year analysis reveals a decrease of 4.18% in 2023. The Compound Annual Growth Rate (CAGR) over the last 5 years was -2.21%, indicating a consistent downtrend. Forecast data suggest this decline will persist, with a projected 5-year CAGR of -4.1%, resulting in an 18.88% decrease by 2028.
Key future trends to watch for include:
• Increasing competition from other countries.
• Changes in China's healthcare policies and demand for pharmaceutical products.
• Potential impact of global regulatory changes on pharmaceutical exports.
• Technological advancements in pharmaceutical manufacturing.
